메뉴 건너뛰기




Volumn 10, Issue 1, 2012, Pages

Cancers of unknown primary origin: Current perspectives and future therapeutic strategies

Author keywords

Cancer; Invasive growth; Metastases; Mutations

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CARBOPLATIN; DOCETAXEL; ERLOTINIB; ETOPOSIDE; GEMCITABINE; OXALIPLATIN; PACLITAXEL; PLATINUM;

EID: 84856071488     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-12     Document Type: Review
Times cited : (83)

References (89)
  • 1
    • 80052724384 scopus 로고    scopus 로고
    • On behalf of the ESMO guidelines working group. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    • Fizazi K, Greco FA, Pavlidis N, Pentheroudakis G. On behalf of the ESMO guidelines working group. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2011, 22(suppl 6):vi64-vi68.
    • (2011) Ann Oncol , vol.22 , Issue.SUPPL. 6
    • Fizazi, K.1    Greco, F.A.2    Pavlidis, N.3    Pentheroudakis, G.4
  • 2
    • 0028241857 scopus 로고
    • Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients
    • Abbruzzese JL, Abbruzzese MC, Hess KR, Raber MN, Lenzi R, Frost P. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 1994, 12(8):1272-1280.
    • (1994) J Clin Oncol , vol.12 , Issue.8 , pp. 1272-1280
    • Abbruzzese, J.L.1    Abbruzzese, M.C.2    Hess, K.R.3    Raber, M.N.4    Lenzi, R.5    Frost, P.6
  • 3
    • 63749106845 scopus 로고    scopus 로고
    • Carcinoma of unknown primary (CUP)
    • 10.1016/j.critrevonc.2008.09.005, 18977667
    • Pavilidis N, Fizazi K. Carcinoma of unknown primary (CUP). Crit Rev Oncol Hematol 2009, 69:271-278. 10.1016/j.critrevonc.2008.09.005, 18977667.
    • (2009) Crit Rev Oncol Hematol , vol.69 , pp. 271-278
    • Pavilidis, N.1    Fizazi, K.2
  • 4
    • 0037294510 scopus 로고    scopus 로고
    • The unknown biology of the unknown primary tumors: a literature review
    • 10.1093/annonc/mdg068, 12562643
    • van de Wouw AJ, Jansen RL, Speel EJ, Hillen HF. The unknown biology of the unknown primary tumors: a literature review. Annals of Oncology 2003, 14(2):191-96. 10.1093/annonc/mdg068, 12562643.
    • (2003) Annals of Oncology , vol.14 , Issue.2 , pp. 191-196
    • van de Wouw, A.J.1    Jansen, R.L.2    Speel, E.J.3    Hillen, H.F.4
  • 5
    • 0014867995 scopus 로고
    • Metastatic cancer of unknown primary site
    • 10.1002/1097-0142(197010)26:4<816::AID-CNCR2820260413>3.0.CO;2-R, 5506606
    • Holmes FF, Fouts TL. Metastatic cancer of unknown primary site. Cancer 1970, 26(4):816-820. 10.1002/1097-0142(197010)26:4<816::AID-CNCR2820260413>3.0.CO;2-R, 5506606.
    • (1970) Cancer , vol.26 , Issue.4 , pp. 816-820
    • Holmes, F.F.1    Fouts, T.L.2
  • 6
    • 0030991577 scopus 로고    scopus 로고
    • Cancer of unknown primary origin
    • Briasoulis E, Pavlidis N. Cancer of unknown primary origin. Oncologist 1997, 2(3):142-152.
    • (1997) Oncologist , vol.2 , Issue.3 , pp. 142-152
    • Briasoulis, E.1    Pavlidis, N.2
  • 7
    • 0037905503 scopus 로고    scopus 로고
    • Diagnostic and therapeutic management of cancer of an unknown primary
    • 10.1016/S0959-8049(03)00547-1, 12957453
    • Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003, 39:1990-2005. 10.1016/S0959-8049(03)00547-1, 12957453.
    • (2003) Eur J Cancer , vol.39 , pp. 1990-2005
    • Pavlidis, N.1    Briasoulis, E.2    Hainsworth, J.3    Greco, F.A.4
  • 8
    • 84859102065 scopus 로고    scopus 로고
    • Subsequent cancers in patients diagnosed with cancer of unknown primary (CUP): etiological insights?
    • Shu X, Liu H, Ji J, Sundquist K, Försti A, Sundquist J, Hemminki K. Subsequent cancers in patients diagnosed with cancer of unknown primary (CUP): etiological insights?. Ann Oncol 2011,
    • (2011) Ann Oncol
    • Shu, X.1    Liu, H.2    Ji, J.3    Sundquist, K.4    Försti, A.5    Sundquist, J.6    Hemminki, K.7
  • 9
    • 0027272258 scopus 로고
    • Treatment of patients with cancer of unknown primary site
    • 10.1056/NEJM199307223290407, 8316270
    • Hainsworth JD, Gereco FA. Treatment of patients with cancer of unknown primary site. N Engl J Med 1993, 329(4):257-263. 10.1056/NEJM199307223290407, 8316270.
    • (1993) N Engl J Med , vol.329 , Issue.4 , pp. 257-263
    • Hainsworth, J.D.1    Gereco, F.A.2
  • 10
    • 81155126081 scopus 로고    scopus 로고
    • Cancer cells regulate biomechanical properties of human microvascular endothelial cells
    • 10.1074/jbc.M111.256172, 21940631
    • Mierke CT. Cancer cells regulate biomechanical properties of human microvascular endothelial cells. J Biol Chem 2011, 286:40025-40037. 10.1074/jbc.M111.256172, 21940631.
    • (2011) J Biol Chem , vol.286 , pp. 40025-40037
    • Mierke, C.T.1
  • 11
    • 34248594553 scopus 로고    scopus 로고
    • Metastases: recent discoveries and novel treatment strategies
    • Ecles SA, Welch DR. Metastases: recent discoveries and novel treatment strategies. Lancet 2007, 307(9574):1742-1757.
    • (2007) Lancet , vol.307 , Issue.9574 , pp. 1742-1757
    • Ecles, S.A.1    Welch, D.R.2
  • 12
    • 77955088689 scopus 로고    scopus 로고
    • Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer
    • 10.1016/j.jneuroim.2010.05.007, 20630606
    • Marchesi F, Locatelli M, Solinas G, Erreni M, Allavena P, Mantovani A. Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer. J Neuroimmunol 2010, 224(1-2):39-44. 10.1016/j.jneuroim.2010.05.007, 20630606.
    • (2010) J Neuroimmunol , vol.224 , Issue.1-2 , pp. 39-44
    • Marchesi, F.1    Locatelli, M.2    Solinas, G.3    Erreni, M.4    Allavena, P.5    Mantovani, A.6
  • 13
    • 54049137191 scopus 로고    scopus 로고
    • Breaching the basement membrane: who, when and how?
    • 10.1016/j.tcb.2008.08.007, 18848450
    • Rowe RG, Weiss SJ. Breaching the basement membrane: who, when and how?. Trends Cell Biol 2008, 18(11):560-574. 10.1016/j.tcb.2008.08.007, 18848450.
    • (2008) Trends Cell Biol , vol.18 , Issue.11 , pp. 560-574
    • Rowe, R.G.1    Weiss, S.J.2
  • 16
    • 59149095123 scopus 로고    scopus 로고
    • Morphology and more specific immunohistochemical stains are fundamental prerequisites in detection of unknown primary cancer
    • Rossi G, Nannini N, Costantini M. Morphology and more specific immunohistochemical stains are fundamental prerequisites in detection of unknown primary cancer. J Clin Oncol 2009, 27(4):649-650.
    • (2009) J Clin Oncol , vol.27 , Issue.4 , pp. 649-650
    • Rossi, G.1    Nannini, N.2    Costantini, M.3
  • 19
    • 44249126754 scopus 로고    scopus 로고
    • Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions
    • 10.1016/S1470-2045(08)70151-7, 18510991
    • Varadhachary GR, Raber MN, Matamoros A, Abbruzzese JL. Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions. Lancet Oncol 2008, 9(6):596-10. 10.1016/S1470-2045(08)70151-7, 18510991.
    • (2008) Lancet Oncol , vol.9 , Issue.6 , pp. 596-610
    • Varadhachary, G.R.1    Raber, M.N.2    Matamoros, A.3    Abbruzzese, J.L.4
  • 20
    • 83755195166 scopus 로고    scopus 로고
    • Cancer of unknown primary
    • Philadelphia: Wolters, Kluwer/Lippincott, Williams and Wilkins, DeVita TV, Hellman S, Rosenberg SA, 9
    • Greco FA, Hainsworth JD. Cancer of unknown primary. Cancer: Principles and Practice of Oncology 2011, 2033-2051. Philadelphia: Wolters, Kluwer/Lippincott, Williams and Wilkins, DeVita TV, Hellman S, Rosenberg SA, 9.
    • (2011) Cancer: Principles and Practice of Oncology , pp. 2033-2051
    • Greco, F.A.1    Hainsworth, J.D.2
  • 21
    • 34250326633 scopus 로고    scopus 로고
    • Forty years experience of treating cancer of unknown primary
    • 10.1080/02841860701243095, 17562435
    • Pavlidis N. Forty years experience of treating cancer of unknown primary. Acta Oncol 2007, 46(5):592-601. 10.1080/02841860701243095, 17562435.
    • (2007) Acta Oncol , vol.46 , Issue.5 , pp. 592-601
    • Pavlidis, N.1
  • 23
    • 31144443692 scopus 로고    scopus 로고
    • Integrated PET/CT: current applications and future directions
    • 10.1148/radiol.2382041977, 16436809
    • von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology 2006, 238(2):405-422. 10.1148/radiol.2382041977, 16436809.
    • (2006) Radiology , vol.238 , Issue.2 , pp. 405-422
    • von Schulthess, G.K.1    Steinert, H.C.2    Hany, T.F.3
  • 24
    • 59949086429 scopus 로고    scopus 로고
    • Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and metaanalysis
    • 10.1007/s00330-008-1194-4, 2816234, 18925401
    • Kwee TC, Kwee RM. Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and metaanalysis. Eur Radiol 2009, 19(3):731-744. 10.1007/s00330-008-1194-4, 2816234, 18925401.
    • (2009) Eur Radiol , vol.19 , Issue.3 , pp. 731-744
    • Kwee, T.C.1    Kwee, R.M.2
  • 25
    • 80052002125 scopus 로고    scopus 로고
    • Nonspecific FDG uptake in the tongue mimicking the primary tumor in a patient with cancer of unknown primary
    • 10.1016/j.clinimag.2010.09.005, 21872134
    • Werner MK, Pfannenberg C, Öksüz M. Nonspecific FDG uptake in the tongue mimicking the primary tumor in a patient with cancer of unknown primary. Clin Imaging 2011, 35(5):405-407. 10.1016/j.clinimag.2010.09.005, 21872134.
    • (2011) Clin Imaging , vol.35 , Issue.5 , pp. 405-407
    • Werner, M.K.1    Pfannenberg, C.2    Öksüz, M.3
  • 27
    • 80255132732 scopus 로고    scopus 로고
    • Extensive screening for primary tumor is redundant in melanoma of unknown primary
    • Tos T, Klyver H, Drzewiecki KT. Extensive screening for primary tumor is redundant in melanoma of unknown primary. J Surg Oncol 2011,
    • (2011) J Surg Oncol
    • Tos, T.1    Klyver, H.2    Drzewiecki, K.T.3
  • 28
    • 79960035419 scopus 로고    scopus 로고
    • Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography
    • Deron PB, Bonte KM, Vermeersch HF, Van de Wiele C. Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography. Cancer Biother Radiopharm 2011, 6(3):331-4.
    • (2011) Cancer Biother Radiopharm , vol.6 , Issue.3 , pp. 331-334
    • Deron, P.B.1    Bonte, K.M.2    Vermeersch, H.F.3    Van de Wiele, C.4
  • 29
    • 79959209221 scopus 로고    scopus 로고
    • Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: A prospective clinical trial
    • 10.1002/hed.21566, 21674668
    • Rudmik L, Lau HY, Matthews TW, Bosch JD, Kloiber R, Molnar CP, Dort JC. Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: A prospective clinical trial. Head Neck 2011, 33(7):935-940. 10.1002/hed.21566, 21674668.
    • (2011) Head Neck , vol.33 , Issue.7 , pp. 935-940
    • Rudmik, L.1    Lau, H.Y.2    Matthews, T.W.3    Bosch, J.D.4    Kloiber, R.5    Molnar, C.P.6    Dort, J.C.7
  • 30
    • 79954507185 scopus 로고    scopus 로고
    • Clinical applications of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary
    • Hu M, Zhao W, Zhang PL, Ju GF, Fu Z, Zhang GL, Kong L, Yang YQ, Ma YD, Yu JM. Clinical applications of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary. Chin Med J (Engl) 2011, 124(7):1010-14.
    • (2011) Chin Med J (Engl) , vol.124 , Issue.7 , pp. 1010-1014
    • Hu, M.1    Zhao, W.2    Zhang, P.L.3    Ju, G.F.4    Fu, Z.5    Zhang, G.L.6    Kong, L.7    Yang, Y.Q.8    Ma, Y.D.9    Yu, J.M.10
  • 31
    • 79952347955 scopus 로고    scopus 로고
    • Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
    • 10.1186/1756-0500-4-56, 3068107, 21385465
    • Park JS, Yim JJ, Kang WJ, Chung JK, Yoo CG, Kim YW, Han SK, Shim YS, Lee SM. Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT. BMC Res Notes 2011, 4:56. 10.1186/1756-0500-4-56, 3068107, 21385465.
    • (2011) BMC Res Notes , vol.4 , pp. 56
    • Park, J.S.1    Yim, J.J.2    Kang, W.J.3    Chung, J.K.4    Yoo, C.G.5    Kim, Y.W.6    Han, S.K.7    Shim, Y.S.8    Lee, S.M.9
  • 32
    • 79961125789 scopus 로고    scopus 로고
    • Clinical implication of (18)F-FDG PET/CT in carcinoma of unknown primary
    • 10.4149/neo_2011_02_135, 21275463
    • Pak K, Kim SJ, Kim IJ, Nam HY, Kim BS, Kim K, Kim YK. Clinical implication of (18)F-FDG PET/CT in carcinoma of unknown primary. Neoplasma 2011, 58(2):135-139. 10.4149/neo_2011_02_135, 21275463.
    • (2011) Neoplasma , vol.58 , Issue.2 , pp. 135-139
    • Pak, K.1    Kim, S.J.2    Kim, I.J.3    Nam, H.Y.4    Kim, B.S.5    Kim, K.6    Kim, Y.K.7
  • 33
    • 81455124034 scopus 로고    scopus 로고
    • Carcinoma of unknown primary in the head and neck: Comparison between positron emission tomography (PET) and PET/CT
    • Keller F, Psychogios G, Linke R, Lell M, Kuwert T, Iro H, Zenk J. Carcinoma of unknown primary in the head and neck: Comparison between positron emission tomography (PET) and PET/CT. Head Neck 2010,
    • (2010) Head Neck
    • Keller, F.1    Psychogios, G.2    Linke, R.3    Lell, M.4    Kuwert, T.5    Iro, H.6    Zenk, J.7
  • 34
    • 79952198571 scopus 로고    scopus 로고
    • Role of 18 F-FDG PET in detecting primary site in the patient with primary unknown carcinoma
    • 10.1007/s00405-010-1371-3, 20814690
    • Yabuki K, Tsukuda M, Horiuchi C, Taguchi T, Nishimura G. Role of 18 F-FDG PET in detecting primary site in the patient with primary unknown carcinoma. Eur Arch Otorhinolaryngol 2010, 267(11):1785-1792. 10.1007/s00405-010-1371-3, 20814690.
    • (2010) Eur Arch Otorhinolaryngol , vol.267 , Issue.11 , pp. 1785-1792
    • Yabuki, K.1    Tsukuda, M.2    Horiuchi, C.3    Taguchi, T.4    Nishimura, G.5
  • 35
    • 77957361098 scopus 로고    scopus 로고
    • Occult squamous cell carcinoma of the uvula detected by F-18 FDG PET/CT in a case of carcinoma of unknown primary in the head and neck
    • 10.1097/RLU.0b013e3181ef09cb, 20838291
    • Salem S, Patel NH, Barwick T, Al-Nahhas A, Howard DJ, Zerizer I, Win Z. Occult squamous cell carcinoma of the uvula detected by F-18 FDG PET/CT in a case of carcinoma of unknown primary in the head and neck. Clin Nucl Med 2010, 35(10):800-801. 10.1097/RLU.0b013e3181ef09cb, 20838291.
    • (2010) Clin Nucl Med , vol.35 , Issue.10 , pp. 800-801
    • Salem, S.1    Patel, N.H.2    Barwick, T.3    Al-Nahhas, A.4    Howard, D.J.5    Zerizer, I.6    Win, Z.7
  • 36
    • 72949100074 scopus 로고    scopus 로고
    • Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT
    • 10.1007/s00259-009-1205-y, 19618183
    • Prasad V, Ambrosini V, Hommann M, Hoersch D, Fanti S, Baum RP. Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT. Eur J Nucl Med Mol Imaging 2010, 37(1):67-77. 10.1007/s00259-009-1205-y, 19618183.
    • (2010) Eur J Nucl Med Mol Imaging , vol.37 , Issue.1 , pp. 67-77
    • Prasad, V.1    Ambrosini, V.2    Hommann, M.3    Hoersch, D.4    Fanti, S.5    Baum, R.P.6
  • 37
    • 60249093424 scopus 로고    scopus 로고
    • Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors
    • 10.1016/j.oraloncology.2008.05.010, 18804404
    • Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol 2009, 45(3):218-224. 10.1016/j.oraloncology.2008.05.010, 18804404.
    • (2009) Oral Oncol , vol.45 , Issue.3 , pp. 218-224
    • Roh, J.L.1    Kim, J.S.2    Lee, J.H.3    Cho, K.J.4    Choi, S.H.5    Nam, S.Y.6    Kim, S.Y.7
  • 38
    • 73949116480 scopus 로고    scopus 로고
    • Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site
    • 10.1002/lary.20638, 19718744
    • Cianchetti M, Mancuso AA, Amdur RJ, Werning JW, Kirwan J, Morris CG, Mendenhall WM. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope 2009, 119(12):2348-2354. 10.1002/lary.20638, 19718744.
    • (2009) Laryngoscope , vol.119 , Issue.12 , pp. 2348-2354
    • Cianchetti, M.1    Mancuso, A.A.2    Amdur, R.J.3    Werning, J.W.4    Kirwan, J.5    Morris, C.G.6    Mendenhall, W.M.7
  • 39
    • 57649220957 scopus 로고    scopus 로고
    • 18-FDG PET in the diagnosis of laterocervical metastases from occult carcinoma
    • 10.1007/s00405-008-0733-6, 18587594
    • Padovani D, Aimoni C, Zucchetta P, Paluzzi A, Pastore A. 18-FDG PET in the diagnosis of laterocervical metastases from occult carcinoma. Eur Arch Otorhinolaryngol 2009, 266(2):267-271. 10.1007/s00405-008-0733-6, 18587594.
    • (2009) Eur Arch Otorhinolaryngol , vol.266 , Issue.2 , pp. 267-271
    • Padovani, D.1    Aimoni, C.2    Zucchetta, P.3    Paluzzi, A.4    Pastore, A.5
  • 41
    • 77951652101 scopus 로고    scopus 로고
    • (18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin
    • Hu M, Li MH, Kong L, Liu NB, Yang GR, Yu JM. (18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin. Zhonghua Zhong Liu Za Zhi 2008, 30(9):699-701.
    • (2008) Zhonghua Zhong Liu Za Zhi , vol.30 , Issue.9 , pp. 699-701
    • Hu, M.1    Li, M.H.2    Kong, L.3    Liu, N.B.4    Yang, G.R.5    Yu, J.M.6
  • 42
    • 53149149849 scopus 로고    scopus 로고
    • Role of fluorodeoxyglucose-PET versus fluorodeoxyglucose-PET/computed tomography in detection of unknown primary tumor: a meta-analysis of the literature
    • Dong MJ, Zhao K, Lin XT, Zhao J, Ruan LX, Liu ZF. Role of fluorodeoxyglucose-PET versus fluorodeoxyglucose-PET/computed tomography in detection of unknown primary tumor: a meta-analysis of the literature. Nucl Med Commun 2008, 29(9):791-802.
    • (2008) Nucl Med Commun , vol.29 , Issue.9 , pp. 791-802
    • Dong, M.J.1    Zhao, K.2    Lin, X.T.3    Zhao, J.4    Ruan, L.X.5    Liu, Z.F.6
  • 43
    • 42549155586 scopus 로고    scopus 로고
    • Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study
    • 10.1002/hed.20734, 18023031
    • Johansen J, Buus S, Loft A, Keiding S, Overgaard M, Hansen HS, Grau C, Bundgaard T, Kirkegaard J, Overgaard J. Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study. Head Neck 2008, 30(4):471-478. 10.1002/hed.20734, 18023031.
    • (2008) Head Neck , vol.30 , Issue.4 , pp. 471-478
    • Johansen, J.1    Buus, S.2    Loft, A.3    Keiding, S.4    Overgaard, M.5    Hansen, H.S.6    Grau, C.7    Bundgaard, T.8    Kirkegaard, J.9    Overgaard, J.10
  • 46
    • 33845753789 scopus 로고    scopus 로고
    • FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary
    • Paul SA, Stoeckli SJ, von Schulthess GK, Goerres GW. FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary. Eur Arch Otorhinolaryngol 2007, 264(2):189-195.
    • (2007) Eur Arch Otorhinolaryngol , vol.264 , Issue.2 , pp. 189-195
    • Paul, S.A.1    Stoeckli, S.J.2    von Schulthess, G.K.3    Goerres, G.W.4
  • 48
    • 33746028189 scopus 로고    scopus 로고
    • A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin
    • 10.2353/jmoldx.2006.050136, 1867609, 16825504
    • Talantov D, Baden J, Jatkoe T, Hahn K, Yu J, Rajpurohit Y, Jiang Y, Choi C, Ross JS, Atkins D, Wang Y, Mazumder A. A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin. J Mol Diagn 2006, 8(3):320-329. 10.2353/jmoldx.2006.050136, 1867609, 16825504.
    • (2006) J Mol Diagn , vol.8 , Issue.3 , pp. 320-329
    • Talantov, D.1    Baden, J.2    Jatkoe, T.3    Hahn, K.4    Yu, J.5    Rajpurohit, Y.6    Jiang, Y.7    Choi, C.8    Ross, J.S.9    Atkins, D.10    Wang, Y.11    Mazumder, A.12
  • 57
    • 0037115537 scopus 로고    scopus 로고
    • French Study Group on Carcinomas of Unknown Primary Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site
    • 10.1200/JCO.2002.04.019, 12488413
    • Culine S, Kramar A, Saghatchian M, Bugat R, Lesimple T, Lortholary A, Merrouche Y, Laplanche A, Fizazi K. French Study Group on Carcinomas of Unknown Primary Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site. J Clin Oncol 2002, 20(24):4679-4683. 10.1200/JCO.2002.04.019, 12488413.
    • (2002) J Clin Oncol , vol.20 , Issue.24 , pp. 4679-4683
    • Culine, S.1    Kramar, A.2    Saghatchian, M.3    Bugat, R.4    Lesimple, T.5    Lortholary, A.6    Merrouche, Y.7    Laplanche, A.8    Fizazi, K.9
  • 58
    • 0036161957 scopus 로고    scopus 로고
    • Epidemiology of unknown primary tumours; incidence and population based survival of 1285 patients in Southeast Netherlands, 1984-1992
    • 10.1016/S0959-8049(01)00378-1, 11818207
    • van de Wouw AJ, Janssen-Heijnen ML, Coebergh JW, Hillen HF. Epidemiology of unknown primary tumours; incidence and population based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur J Cancer 2002, 38:409-413. 10.1016/S0959-8049(01)00378-1, 11818207.
    • (2002) Eur J Cancer , vol.38 , pp. 409-413
    • van de Wouw, A.J.1    Janssen-Heijnen, M.L.2    Coebergh, J.W.3    Hillen, H.F.4
  • 59
    • 82555187093 scopus 로고    scopus 로고
    • Carcinomas of an unknown primary origin-diagnosis and treatment
    • 10.1038/nrclinonc.2011.158, 22048624
    • Massard C, Loriot Y, Fizazi K. Carcinomas of an unknown primary origin-diagnosis and treatment. Nat Rev Clin Oncol 2011, 8(12):701-710. 10.1038/nrclinonc.2011.158, 22048624.
    • (2011) Nat Rev Clin Oncol , vol.8 , Issue.12 , pp. 701-710
    • Massard, C.1    Loriot, Y.2    Fizazi, K.3
  • 60
    • 70350361222 scopus 로고    scopus 로고
    • Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis
    • 10.1016/j.ctrv.2009.05.005, 19539430
    • Golfinopoulos V, Pentheroudakis G, Salanti G, Nearchou AD, Ioannidis JP, Pavlidis N. Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis. Cancer Treat Rev 2009, 35:570-573. 10.1016/j.ctrv.2009.05.005, 19539430.
    • (2009) Cancer Treat Rev , vol.35 , pp. 570-573
    • Golfinopoulos, V.1    Pentheroudakis, G.2    Salanti, G.3    Nearchou, A.D.4    Ioannidis, J.P.5    Pavlidis, N.6
  • 62
    • 16644368148 scopus 로고    scopus 로고
    • A phase II study of paclitaxel plus cisplatin chemotherapy in an unfavourable group of patients with cancer of unknown primary site
    • 10.1093/jjco/hyh124, 15613558
    • Park YH, Ryoo BY, Choi SJ, Yang SH, Kim HT. A phase II study of paclitaxel plus cisplatin chemotherapy in an unfavourable group of patients with cancer of unknown primary site. Jpn J Clin Oncol 2004, 34(11):681-685. 10.1093/jjco/hyh124, 15613558.
    • (2004) Jpn J Clin Oncol , vol.34 , Issue.11 , pp. 681-685
    • Park, Y.H.1    Ryoo, B.Y.2    Choi, S.J.3    Yang, S.H.4    Kim, H.T.5
  • 63
    • 51149110316 scopus 로고    scopus 로고
    • Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study
    • 10.1080/02841860701843043, 18607872, Hellenic Cooperative Oncology Group
    • Pentheroudakis G, Briasoulis E, Kalofonos HP, Fountzilas G, Economopoulos T, Samelis G, Koutras A, Karina M, Xiros N, Samantas E, Bamias A, Pavlidis N, . Hellenic Cooperative Oncology Group Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study. Acta Oncol 2008, 47(6):1148-1155. 10.1080/02841860701843043, 18607872, Hellenic Cooperative Oncology Group.
    • (2008) Acta Oncol , vol.47 , Issue.6 , pp. 1148-1155
    • Pentheroudakis, G.1    Briasoulis, E.2    Kalofonos, H.P.3    Fountzilas, G.4    Economopoulos, T.5    Samelis, G.6    Koutras, A.7    Karina, M.8    Xiros, N.9    Samantas, E.10    Bamias, A.11    Pavlidis, N.12
  • 64
    • 0037087627 scopus 로고    scopus 로고
    • Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study
    • 10.1200/JCO.20.6.1651, 11896116
    • Greco FA, Burris HA, Litchy S, Barton JH, Bradof JE, Richards P, Scullin DC, Erland JB, Morrissey LH, Hainsworth JD. Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study. J Clin Oncol 2002, 20(6):1651-1656. 10.1200/JCO.20.6.1651, 11896116.
    • (2002) J Clin Oncol , vol.20 , Issue.6 , pp. 1651-1656
    • Greco, F.A.1    Burris, H.A.2    Litchy, S.3    Barton, J.H.4    Bradof, J.E.5    Richards, P.6    Scullin, D.C.7    Erland, J.B.8    Morrissey, L.H.9    Hainsworth, J.D.10
  • 65
    • 0031004065 scopus 로고    scopus 로고
    • Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide
    • Hainsworth JD, Erland JB, Kalman LA, Schreeder MT, Greco FA. Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide. J Clin Oncol 1997, 15(6):2385-2393.
    • (1997) J Clin Oncol , vol.15 , Issue.6 , pp. 2385-2393
    • Hainsworth, J.D.1    Erland, J.B.2    Kalman, L.A.3    Schreeder, M.T.4    Greco, F.A.5
  • 66
    • 75449086584 scopus 로고    scopus 로고
    • Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site
    • 10.1634/theoncologist.2009-0112, 19965914
    • Hainsworth JD, Spigel DR, Thompson DS, Murphy PB, Lane CM, Waterhouse DM, Naot Y, Greco FA. Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site. Oncologist 2009, 14(12):1189-9. 10.1634/theoncologist.2009-0112, 19965914.
    • (2009) Oncologist , vol.14 , Issue.12 , pp. 1189-1189
    • Hainsworth, J.D.1    Spigel, D.R.2    Thompson, D.S.3    Murphy, P.B.4    Lane, C.M.5    Waterhouse, D.M.6    Naot, Y.7    Greco, F.A.8
  • 68
    • 77951246611 scopus 로고    scopus 로고
    • Capecitabine and oxaliplatin as second-line treatment in patients with carcinoma of unknown primary site
    • 10.3109/02841861003649240, 20235750
    • Møller AK, Pedersen KD, Abildgaard J, Petersen BL, Daugaard G. Capecitabine and oxaliplatin as second-line treatment in patients with carcinoma of unknown primary site. Acta Oncol 2010, 49(4):431-435. 10.3109/02841861003649240, 20235750.
    • (2010) Acta Oncol , vol.49 , Issue.4 , pp. 431-435
    • Møller, A.K.1    Pedersen, K.D.2    Abildgaard, J.3    Petersen, B.L.4    Daugaard, G.5
  • 69
    • 77952566280 scopus 로고    scopus 로고
    • Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium
    • Hainsworth JD, Spigel DR, Burris HA, Shipley D, Farley C, Macias-Perez IM, Barton J, Greco FA. Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium. Cancer 2010, 116(10):2448-2454.
    • (2010) Cancer , vol.116 , Issue.10 , pp. 2448-2454
    • Hainsworth, J.D.1    Spigel, D.R.2    Burris, H.A.3    Shipley, D.4    Farley, C.5    Macias-Perez, I.M.6    Barton, J.7    Greco, F.A.8
  • 70
    • 79957994713 scopus 로고    scopus 로고
    • Unknown primary cancer of the head and neck: a multidisplinary approach
    • 10.1007/s12094-011-0624-y, 21324796
    • Cerezo L, raboso E, Ballestreros AI. Unknown primary cancer of the head and neck: a multidisplinary approach. Clin Transl Oncol 2011, 13(2):88-97. 10.1007/s12094-011-0624-y, 21324796.
    • (2011) Clin Transl Oncol , vol.13 , Issue.2 , pp. 88-97
    • Cerezo, L.1    raboso, E.2    Ballestreros, A.I.3
  • 73
    • 0031687805 scopus 로고    scopus 로고
    • Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: outcomes and patterns of failure
    • 10.1002/(SICI)1097-0347(199812)20:8<674::AID-HED3>3.0.CO;2-H, 9790287
    • Colletier PJ, Garden AS, Morrison WH, Goepfert H, Geara F, Ang KK. Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: outcomes and patterns of failure. Head Neck 1998, 20(8):674-681. 10.1002/(SICI)1097-0347(199812)20:8<674::AID-HED3>3.0.CO;2-H, 9790287.
    • (1998) Head Neck , vol.20 , Issue.8 , pp. 674-681
    • Colletier, P.J.1    Garden, A.S.2    Morrison, W.H.3    Goepfert, H.4    Geara, F.5    Ang, K.K.6
  • 74
    • 79952093910 scopus 로고    scopus 로고
    • Familial risks in cancer of unknown primary: tracking the primary sites
    • 10.1200/JCO.2010.31.5614, 21189391
    • Hemminki K, Ji J, Sundquist J, Shu X. Familial risks in cancer of unknown primary: tracking the primary sites. J Clin Oncol 2011, 29(4):435-440. 10.1200/JCO.2010.31.5614, 21189391.
    • (2011) J Clin Oncol , vol.29 , Issue.4 , pp. 435-440
    • Hemminki, K.1    Ji, J.2    Sundquist, J.3    Shu, X.4
  • 76
    • 0021927525 scopus 로고
    • Metastatic adenocarcinoma of unknown primary site: abnormalities of cellular DNA content and survival
    • 10.1016/0277-5379(85)90171-3, 3987755
    • Hedley DW, Leary JA, Kirsten F. Metastatic adenocarcinoma of unknown primary site: abnormalities of cellular DNA content and survival. Eur J Cancer Clin Oncol 1985, 21(2):185-189. 10.1016/0277-5379(85)90171-3, 3987755.
    • (1985) Eur J Cancer Clin Oncol , vol.21 , Issue.2 , pp. 185-189
    • Hedley, D.W.1    Leary, J.A.2    Kirsten, F.3
  • 77
    • 0029549980 scopus 로고
    • Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary origin
    • Pavlidis N, Briassoulis E, Bai M, Fountzilas G, Agnantis N. Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary origin. Anticancer Res 1995, 15(6B):2563-2567.
    • (1995) Anticancer Res , vol.15 , Issue.6 B , pp. 2563-2567
    • Pavlidis, N.1    Briassoulis, E.2    Bai, M.3    Fountzilas, G.4    Agnantis, N.5
  • 79
    • 34247611517 scopus 로고    scopus 로고
    • Global profiling of EGFR gene mutation, amplification, regulation and tissue protein expression in unknown primary carcinomas: to target or not to target?
    • 10.1007/s10585-007-9055-0, 17390112
    • Dova L, Pentheroudakis G, Georgiou I, Malamou-Mitsi V, Vartholomatos G, Fountzilas G, Kolaitis N, Kitsiou E, Pavlidis N. Global profiling of EGFR gene mutation, amplification, regulation and tissue protein expression in unknown primary carcinomas: to target or not to target?. Clin Exp Metastasis 2007, 24(2):79-86. 10.1007/s10585-007-9055-0, 17390112.
    • (2007) Clin Exp Metastasis , vol.24 , Issue.2 , pp. 79-86
    • Dova, L.1    Pentheroudakis, G.2    Georgiou, I.3    Malamou-Mitsi, V.4    Vartholomatos, G.5    Fountzilas, G.6    Kolaitis, N.7    Kitsiou, E.8    Pavlidis, N.9
  • 80
    • 0027331870 scopus 로고
    • P53 gene mutation spectrum in human unknown primary tumors
    • Bar-Eli M, Abbruzzese JL, Lee-Jackson, Frost P. p53 gene mutation spectrum in human unknown primary tumors. Anticancer Res 1993, 13(5A):1619-1623.
    • (1993) Anticancer Res , vol.13 , Issue.5 A , pp. 1619-1623
    • Bar-Eli, M.1    Abbruzzese, J.L.2    Lee-Jackson3    Frost, P.4
  • 81
    • 80052334435 scopus 로고    scopus 로고
    • Hypoxia-related protein expression and its clinicopathologic implication in carcinoma of unknown primary
    • 10.1007/s13277-011-0190-5, 21598042
    • Koo JS, Kim H. Hypoxia-related protein expression and its clinicopathologic implication in carcinoma of unknown primary. Tumour Biol 2011, 32(5):893-904. 10.1007/s13277-011-0190-5, 21598042.
    • (2011) Tumour Biol , vol.32 , Issue.5 , pp. 893-904
    • Koo, J.S.1    Kim, H.2
  • 82
    • 0036551486 scopus 로고    scopus 로고
    • Scatter factor and semaphorin receptors: cell signalling for invasive growth
    • 10.1038/nrc779, 12001990
    • Trusolino L, Comoglio PM. Scatter factor and semaphorin receptors: cell signalling for invasive growth. Nat Rev Cancer 2002, 2(4):289-300. 10.1038/nrc779, 12001990.
    • (2002) Nat Rev Cancer , vol.2 , Issue.4 , pp. 289-300
    • Trusolino, L.1    Comoglio, P.M.2
  • 83
    • 33746504571 scopus 로고    scopus 로고
    • Invasive growth: a MET-driven genetic programme for cancer and stem cells
    • 10.1038/nrc1912, 16862193
    • Boccaccio C, Comoglio PM. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer 2006, 6(8):637-645. 10.1038/nrc1912, 16862193.
    • (2006) Nat Rev Cancer , vol.6 , Issue.8 , pp. 637-645
    • Boccaccio, C.1    Comoglio, P.M.2
  • 84
    • 0037478437 scopus 로고    scopus 로고
    • Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
    • 10.1016/S1535-6108(03)00085-0, 12726861
    • Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003, 3(4):347-361. 10.1016/S1535-6108(03)00085-0, 12726861.
    • (2003) Cancer Cell , vol.3 , Issue.4 , pp. 347-361
    • Pennacchietti, S.1    Michieli, P.2    Galluzzo, M.3    Mazzone, M.4    Giordano, S.5    Comoglio, P.M.6
  • 86
    • 78649420006 scopus 로고    scopus 로고
    • MET signalling: principles and functions in development, organ regeneration and cancer
    • 10.1038/nrm3012, 21102609
    • Trusolino L, Bertotti A, Comoglio PM. MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 2010, 11(12):834-848. 10.1038/nrm3012, 21102609.
    • (2010) Nat Rev Mol Cell Biol , vol.11 , Issue.12 , pp. 834-848
    • Trusolino, L.1    Bertotti, A.2    Comoglio, P.M.3
  • 87
    • 77958483335 scopus 로고    scopus 로고
    • Targeting the MET oncogene in cancer and metastases
    • 10.1517/13543784.2010.522988, 20868306
    • Stella GM, Benvenuti S, Comoglio PM. Targeting the MET oncogene in cancer and metastases. Expert Opin Investig Drugs 2010, 19(11):1381-1394. 10.1517/13543784.2010.522988, 20868306.
    • (2010) Expert Opin Investig Drugs , vol.19 , Issue.11 , pp. 1381-1394
    • Stella, G.M.1    Benvenuti, S.2    Comoglio, P.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.